Paeds Cases · allergy-and-immunology
Counsel a family on rituximab-related secondary hypogammaglobulinaemia and prophylaxis — OSCE
OSCE communication and shared-planning station: explaining secondary immunodeficiency arising from a biologic (rituximab) given for nephrotic syndrome, why immunoglobulin replacement is driven by infection burden rather than a single low number, the role of antimicrobial prophylaxis and safe vaccination, and the generally good prognosis with consistent follow-up — while addressing fear and avoiding the over-treatment trap.
On this page & tools
Target exams
Candidate brief
You have eight minutes to counsel the parents of a six-year-old girl whose immunoglobulins have fallen after rituximab for nephrotic syndrome and who has had recent chest infections. The secondary immunodeficiency is iatrogenic and may be reversible. Use a structured, honest, empathic approach. [2] [1]
Key teaching and communication objectives
Acknowledge and validate the parents' fear before delivering information. Explain that "secondary immunodeficiency" means her immunity has been temporarily affected by a treatment, not that she was born with a permanent immune condition, and that the affected cells usually recover over many months. [2] [3]
Explain the next steps in plain language: confirm whether the low level is causing real infection susceptibility with a functional vaccine response and a careful infection history, because immunoglobulin replacement is decided by infection burden, not by the number alone. Address the online concern honestly: some forms of low antibody are permanent, but rituximab-related depletion usually recovers as B cells return, so a lifelong commitment is not assumed. [1] [3]
Describe the protection plan: prompt treatment of any new infection, consideration of antibiotic prophylaxis if infections continue, and safe vaccination (she can have her routine inactivated vaccines, but live vaccines are held while her immunity is suppressed, and her household contacts stay fully up to date). [1]
Close with a shared plan and a clear next appointment, framed around surveillance as her B cells recover, and an offer of written information and contact with a patient-support organisation. [2]
References
- [1]Otani IM, Lehman HK, Jongco AM, et al. Practical guidance for the diagnosis and management of secondary hypogammaglobulinemia: A Work Group Report. J Allergy Clin Immunol, 2022.PMID 35176351
- [2]Chan EY, Yap DY, Colucci M, et al. Use of Rituximab in Childhood Idiopathic Nephrotic Syndrome. Clin J Am Soc Nephrol, 2023.PMID 36456193
- [3]Chinen J, Shearer WT. Secondary immunodeficiencies, including HIV infection. J Allergy Clin Immunol, 2010.PMID 20042227